Literature DB >> 25147374

Asparaginase allergies: it's all in the genes.

Meir Wetzler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25147374      PMCID: PMC4141504          DOI: 10.1182/blood-2014-07-585919

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.

Authors:  S-H Chen; D Pei; W Yang; C Cheng; S Jeha; N J Cox; W E Evans; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

2.  HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis.

Authors:  C Fusco; V Andreone; G Coppola; V Luongo; F Guerini; E Pace; C Florio; G Pirozzi; R Lanzillo; P Ferrante; P Vivo; M Mini; M Macrì; G Orefice; M L Lombardi
Journal:  Neurology       Date:  2001-12-11       Impact factor: 9.910

3.  Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.

Authors:  Lisa F Barcellos; Stephen Sawcer; Patricia P Ramsay; Sergio E Baranzini; Glenys Thomson; Farren Briggs; Bruce C A Cree; Ann B Begovich; Pablo Villoslada; Xavier Montalban; Antonio Uccelli; Giovanni Savettieri; Robin R Lincoln; Carolyn DeLoa; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen L Hauser; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2006-08-11       Impact factor: 6.150

4.  Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.

Authors:  Paul V Plourde; Sima Jeha; Nobuko Hijiya; Frank G Keller; Lewis B Silverman; Susan R Rheingold; ZoAnn E Dreyer; Gary V Dahl; Taheri Mercedes; Chinglin Lai; Tim Corn
Journal:  Pediatr Blood Cancer       Date:  2014-01-16       Impact factor: 3.167

5.  A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.

Authors:  M B Bornstein; A Miller; S Slagle; M Weitzman; H Crystal; E Drexler; M Keilson; A Merriam; S Wassertheil-Smoller; V Spada
Journal:  N Engl J Med       Date:  1987-08-13       Impact factor: 91.245

6.  Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients.

Authors:  Jonathan K Armstrong; Georg Hempel; Susanne Koling; Linda S Chan; Timothy Fisher; Herbert J Meiselman; George Garratty
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

7.  HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.

Authors:  Christian A Fernandez; Colton Smith; Wenjian Yang; Mihir Daté; Donald Bashford; Eric Larsen; W Paul Bowman; Chengcheng Liu; Laura B Ramsey; Tamara Chang; Victoria Turner; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Suna Onengut-Gumuscu; Wei-Min Chen; Patrick Concannon; Stephen S Rich; Paul Scheet; Sima Jeha; Ching-Hon Pui; William E Evans; Meenakshi Devidas; Mary V Relling
Journal:  Blood       Date:  2014-06-26       Impact factor: 22.113

8.  Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.

Authors:  L Lennard; J S Lilleyman; J Van Loon; R M Weinshilboum
Journal:  Lancet       Date:  1990-07-28       Impact factor: 79.321

Review 9.  HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.

Authors:  Chi-Yuan Cheng; Shih-Chi Su; Chi-Hua Chen; Wei-Li Chen; Shin-Tarng Deng; Wen-Hung Chung
Journal:  J Immunol Res       Date:  2014-05-08       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.